16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate (SSR). Doximity (DOCS) priced above the range to raise...read more
Miromatrix Medical, a developing novel bioengineering technology for organ transplants, raised $43 million by offering 4.8 million shares at $9, the high end of the range of $7 to $9. The company offered 0.8 million more shares than anticipated. Miromatrix is developing a novel technology for bioengineering fully transplantable human organs, with an initial focus on human livers...read more
Updated Monday, 6/21/21. 17 IPOs are scheduled to raise $6.3 billion in the week ahead, led by two billion-dollar deals. Chinese freight platform Full Truck Alliance (YMM) plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights,...read more
Miromatrix Medical, which is developing novel bioengineering technology for organ transplants, announced terms for its IPO on Wednesday.
The Eden Prairie, MN-based company plans to raise $32 million by offering 4 million shares at a price range of $7 to $9. At the midpoint of the proposed range, Miromatrix Medical would command a fully diluted market value of $162 million.
...read more
US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week
16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate (SSR). Doximity (DOCS) priced above the range to raise...read more
Organ bioengineering company Miromatrix Medical prices upsized IPO at $9 high end
Miromatrix Medical, a developing novel bioengineering technology for organ transplants, raised $43 million by offering 4.8 million shares at $9, the high end of the range of $7 to $9. The company offered 0.8 million more shares than anticipated. Miromatrix is developing a novel technology for bioengineering fully transplantable human organs, with an initial focus on human livers...read more
US IPO Week Ahead: Billion-dollar deals come to market in a 17 IPO week
Updated Monday, 6/21/21. 17 IPOs are scheduled to raise $6.3 billion in the week ahead, led by two billion-dollar deals. Chinese freight platform Full Truck Alliance (YMM) plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights,...read more
Organ bioengineering company Miromatrix Medical sets terms for $32 million IPO
Miromatrix Medical, which is developing novel bioengineering technology for organ transplants, announced terms for its IPO on Wednesday. The Eden Prairie, MN-based company plans to raise $32 million by offering 4 million shares at a price range of $7 to $9. At the midpoint of the proposed range, Miromatrix Medical would command a fully diluted market value of $162 million. ...read more